Category

2019

2019 Continuing Education Information

2019 AAPM Annual Meeting Continuing Education Information

The AAPM 35th Annual Meeting & Preconferences took place March 6-10, 2019, at the Colorado Convention Center in Denver, CO. Thank you to everyone who participated. Below please find important information about the meeting educational programming. Refer to the Past Meeting Archive for additional information about the 2019 AAPM Annual Meeting.

Who Should Attend?

Clinicians treating patients in pain are invited to join leading experts in pain medicine at AAPM35. The program has been designed by a multidisciplinary, multimodal committee of experts at the forefront of pain medicine practice. It is designed for a primary audience of physicians whose scope of practice is targeted at the multidisciplinary practice of pain medicine and nonphysician healthcare clinicians, including nursemedis, nurse practitioners, physician assistants, physical therapists, psychologists, and pharmacists who are part of the multidisciplinary pain management team.

Objectives and Desired Outcomes

After attending the meeting, participants should be better able to

  • Describe to pain medicine clinicians the recent advancements in research, clinical best practices, patient management, practice management, and the diagnosis and treatment of patients in pain
  • Assess, treat, and improve outcomes for patients suffering from multiple types of pain through the use of evidence-based integrative/multidisciplinary pain management strategies and patient-centered treatment plans
  • Improve patient safety and decrease the rate of opioid- and pain analgesic–related adverse events.

Accreditation Statements

The American Academy of Pain Medicine (AAPM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

35th Annual Meeting

AAPM designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pain Medicine Best Practices: Integrative Solutions for Critical Challenges Preconference

AAPM designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Opioid and Non-Opioid Medications Management: Filling in the Gaps, Prescribing for the Whole Patient Preconference

AAPM designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Physician Assistants (AAPA)

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from accredited organizations, including AAPM.

American Psychological Association (APA)

Select sessions for the AAPM 35th Annual Meeting have been reviewed and approved by the APA Office of Continuing Education in Psychology (CEP) to offer Continuing Education (CE) credit for psychologists. Full attendance was required at each session for which you are claiming APA CE credit. Partial credit is not awarded. The CEP Office maintains responsibility for the delivery of the session. Approval #2019002. If you are claiming APA credits, select “Other Clinician” when completing your evaluation. Full attendance was required at each session for which you are claiming APA CE credit. As an APA credit claimant, you should have had your attendee badge scanned by a door-checker prior to attending or departing each of your education sessions in order for APA to have a record of your attendance at each session in order to issue APA credits. APA issues APA certificates directly. Claimants must also complete and online evaluation prior to receiving credit from APA. A $100 fee to claim APA CE credit will apply. Call AAPM at 847-375-4731 for more information.

Nursing Credits

This continuing nursing education activity was approved by the American Association of Neuroscience Nurses, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. AANN Approval Code: 0307/15.75/02

Note: Attendees cannot receive credit for simultaneous sessions.

MOCA 2.0® Credits

Participants in the AAPM 35th Annual Meeting, Pain Medicine Best Practices: Integrative Solutions for Critical Challenges Preconference, Opioid and Non-Opioid Medications Management: Filling the Gaps, Prescribing for the Whole Patient Preconference and/or Ultrasound-Guided Acute and Chronic Pain Medicine Interventions Preconference will receive MOCA 2.0® credit after evaluations have been submitted online. AAPM will report participant completion data to the American Board of Anesthesiology via the ACCME’s Program and Activity Reporting System (PARS) on behalf of the participant in a timely manner. Maintenance of Certification in Anesthesiology Program® and MOCA 2.0® are registered trademarks of the American Board of Anesthesiology®. This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, theABA.org, for a list of all MOCA 2.0® requirements.

MOC Part II Lifelong Learning

Participants in the AAPM 35 Annual Meeting, Pain Medicine Best Practices: Integrative Solutions for Critical Challenges Preconference, Opioid and Non-Opioid Medications Management: Filling the Gaps, Prescribing for the Whole Patient Preconference and/or Ultrasound-Guided Acute and Chronic Pain Medicine Interventions Preconference will receive ABPMR MOC Part II Lifelong Learning CME credit after evaluations have been submitted online. Participants will need to report these CME credits directly into their ABPMR MOC Homepage.

Evaluation Tool & Claiming CME Credit

Meeting registrants can access the evaluation by visiting the AAPM website at painmed.org/denver and clicking on the evaluation link. Participants will receive their CME certificate only after they submit their evaluations online. Certificates also can be sent to participants’ email addresses for printing later or saving electronically. All attendees are encouraged to complete the meeting evaluation by May 31, 2019, regardless of whether they are seeking continuing education credits. The final evaluation deadline for the Annual Meeting is December 31, 2019. If you have any questions, please call 847-375-4731.

Commercial Support

The AAPM 35th Annual Meeting is supported in part by educational grants from the following commercial supporters as of February 19, 2019: Boston Scientific Corporation; Daiichi Sankyo, Inc., and Salix Pharmaceuticals, Inc., a Division of Valeant Pharmaceuticals North America LLC.

The Pain Medicine Best Practices: Integrative Solutions for Critical Challenges Preconference is supported in part by educational grants from the following commercial supporters, as February 19, 2019: Boston Scientific.

The 2019 Ultrasound-Guided Acute and Chronic Pain Medicine Interventions course is supported in part by donated in-kind durable equipment borrowed from the following companies as of February 21, 2019: Avanos, Bioness, Boston Scientific, Clarius Mobile Health, FUJIFILM SonoSite, GE Healthcare, NeuroLogica/Samsung, RGS Healthcare, Safersonic, and SPR Therapeutics.

Disclosure of Conflicts of Interest

It is the policy of AAPM to plan and implement educational activities in accordance with the ACCME to ensure balance, independence, objectivity, and scientific rigor. As an ACCME-accredited provider, AAPM may receive commercial support from industry providers but does not receive guidance, either nuanced or direct, on the content of the activity or on who should deliver the content.

As an ACCME-accredited provider, AAPM must demonstrate that everyone who is in a position to control the content of an education activity has disclosed all relevant financial relationships with any commercial interest. Relevant financial relationships are defined as financial relationships with any commercial interests in any amount occurring within the past 12 months that create a conflict of interest. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. Providers of clinical service directly to patients are NOT commercial interests. Employees of commercial interests are ineligible to submit an educational session proposal for consideration.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria for promotional speakers’ bureau, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. Financial relationships of the person involved in the CME activity should also include financial relationships of a spouse or partner. An individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity. Relevant financial relationships (or a statement of lack thereof) must be disclosed to the learner audience in advance of the activity.

Access the full list of Planning Committee and faculty disclosures.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. The American Academy of Pain Medicine does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization(s) associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use information presented at the 35th Annual Meeting to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Further, the opinions expressed at the 35th Annual Meeting are those of the faculty and do not necessarily represent the views of AAPM. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

2019 Commercially Supported Symposia

2019 Commercially Supported Symposia

The following Commercially Supported Symposia (CSS) held during the AAPM 35th Annual Meeting & Preconferences March 7-9, 2019 offered meeting attendees an opportunity to expand their pain management knowledge and gain insight into the important topics and issues facing today’s pain specialists.

Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention

Migraine, a common neurovascular brain disorder, represents a severe and widespread health problem. In recent years a number of novel therapies for the acute treatment and prevention of migraine have been developed. These include centrally acting serotonin (5HT1F) agonists and therapies directed against the calcitonin gene-related peptide (CGRP) ligand and its receptor. During this PeerView Live lunch symposium, after briefly reviewing how migraine can be identified in clinical practice, experts in the management of this neurologic disorder will discuss the latest data on emerging therapies for the acute treatment of migraine, assess current data on approved and emerging anti-CGRP monoclonal antibodies for migraine prevention, and highlight key considerations for using these therapies in clinical practice.

Educational Objectives

  • Apply established screening tools and criteria for migraine diagnosis in clinical practice.
  • Identify data on the efficacy, safety, and tolerability of established and emerging therapeutics for the acute treatment of migraine.
  • Cite updated evidence on available and emerging therapies for the prevention of migraine.
  • Employ strategies to integrate emerging therapies for acute treatment and headache prevention into personalized management plans for patients with migraine if/when these agents are approved in the future.

This activity is supported by an educational grant from Lilly.

The Long Lasting Impact of a Short Conversation About Opioid Overdose Risks

Despite mounting concern and efforts to address opioid overdose in the United States, death rates involving prescription opioids have not abated. This statistic highlights missed opportunities for clinicians to intervene to help save lives. Numerous government agencies and professional organizations recommend that clinicians co-prescribe take-home naloxone with opioids for at-risk patients as a precaution to help prevent opioid overdose deaths. While it is necessary to first identify patients at risk of an opioid overdose, just as important is engaging in conversations that can help save patients’ lives. The faculty will model a brief and impactful conversation with patients and care partners in a way that facilitates patient acceptance to take-home naloxone being part of their chronic pain treatment plan.

Please see Important Safety Information and full Prescribing Information.

Educational Objectives

After attending this symposium, participants should be better able to:

  • Identify patients at risk for an opioid overdose.
  • Facilitate brief and impactful conversations with patients and care partners around risk of opioid overdose and the need for take-home naloxone.
  • Implement strategies to incorporate communication about opioid overdose and take-home naloxone into clinical protocols when prescribing opioids.

Activity sponsored by kaleo, Inc.

Opioid Therapy Insights: A Holistic Approach to Managing Patients

In this interactive, industry-sponsored presentation, we will discuss when to consider an abuse-deterrent opioid for chronic pain. We will also explore treatment options for opioid-induced constipation in adult patients with chronic non-cancer pain.

Activity sponsored by Daiichi Sankyo, Inc. & Inspirion Delivery Sciences.

Alternative Options to the Management of Chronic Pain

To review and discuss the unique pharmacologic properties, clinical efficacy, and use of an alternative option for the management of chronic pain.

Activity sponsored by BioDelivery Sciences International, Inc.

Exploring the Burden, Diagnosis and Treatment of Migraine: What Pain Specialists Need to Know

This presentation discussed migraine diagnosis, classification, and treatment as well as migraine-associated patient burden.

Activity sponsored by Novartis and Amgen.

2019 Attendee Page

2019 Annual Meeting Attendee Page

Use your AAPM login information to access session handouts, online evaluations, and the meeting attendee list.

Session Handouts

Paper copies of handouts will not be provided at the meeting and should be printed out in advance if needed. All slide presentations that were submitted to AAPM by speakers in advance of the meeting are available for download. Any presenter slides that were not submitted in advance will be available following the Annual Meeting.

Evaluations

Access session evaluations and claim CME/CE certificates. Completing a meeting evaluation through the online evaluation process is the only way to receive your CME/CE certificate(s).

Attendee List

See who among your colleagues is also registered to participate in the AAPM 35th Annual Meeting & Preconferences by downloading the attendee list.

For assistance, contact AAPM at [email protected] or 847-375-4731.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound
Pain Medicine Journal
Access to this page is restricted to members only! Not a mamber? Join Now!

Ask Us Anything. Anytime.

📝 Fill in your details and we’ll get back to you in no time.
AAPM

American Academy of Pain Medicine